NCT02492984 PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Hemophilia A Status COMPLETED Phase PHASE4
NCT02483208 Single Dose Study in Subjects With Severe Hemophilia A Comparing Pharmacokinetic Parameters for BAY81-8973 and Advate Status COMPLETED Phase PHASE1
NCT02479087 Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients Status UNKNOWN Phase PHASE4
NCT02476942 A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment Status COMPLETED Phase N/A
NCT02461992 Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia A Status COMPLETED Phase PHASE1
NCT02418793 A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B Status COMPLETED Phase PHASE1
NCT02402829 A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture Status TERMINATED Phase N/A
NCT02396862 Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment Status COMPLETED Phase N/A
NCT02392156 Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes Status TERMINATED Phase N/A
NCT02362581 Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A Status COMPLETED Phase NA
NCT02319070 2-cohort Study of Adult Patients With Severe Hemophilia A in Greece Status COMPLETED Phase N/A
NCT02282410 Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A Status UNKNOWN Phase NA
NCT02280265 Efficacy and Safety of ADVATE Standard Prophylaxis to Hemophilia A Status UNKNOWN Phase NA
NCT02263066 Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis Status COMPLETED Phase N/A
NCT02234323 An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A Status COMPLETED Phase PHASE3
NCT02225483 Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function Status COMPLETED Phase N/A
NCT02199717 An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia Status COMPLETED Phase N/A
NCT02190149 Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS Status COMPLETED Phase N/A